M. Joyce Nirmala
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
M. Joyce Nirmala has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Latha Durai
Multi Disciplinary Research Unit, Chengalpattu Medical College, Chengalpattu, India
4 shared publications- Amitava Mukherjee
Centre for Nanobiotechnology, Vellore Institute of Technology, Vellore 632014, Tamil Nadu, India
3 shared publications - Ramamurthy Nagarajan
Department of Chemical Engineering, Indian Institute of Technology Madras, Chennai 600 036, India
2 shared publications Vineet Gopakumar
Department of Chemical Engineering, Indian Institute of Technology Madras, Chennai 600 036, India
2 shared publicationsAbhrajit Debroy
Centre for Nanobiotechnology, Vellore Institute of Technology, Vellore 632014, India
1 shared publication- Akila Kesavan1 shared publication
Latest Publications
- 25 November 2025
- Published by The Organoid Society in Organoid
- Vol. 5
Three-dimensional bioprinting techniques for cancer: organoid models and applications
Three-dimensional (3D) bioprinting has emerged as a promising technology for cancer research and treatment, offering unprecedented capabilities for fabricating complex tissue models and enabling personalized medicine. This review provides an overview of 3D bioprinting applications in cancer research, with a particular focus on organoid models. Organoid models, generated from patient-derived cells, have attracted considerable attention for their ability to reproduce the cellular and architectural complexity of tumors. The integration of 3D bioprinting technology into organoid generation allows precise assembly of multiple cell types, extracellular matrix components, and biomaterials, thereby enabling the creation of realistic tumor microenvironments. These bioprinted organoid models serve as valuable tools for studying cancer progression, conducting drug screening, and advancing personalized therapy.
- 25 November 2025
- Published by The Organoid Society in Organoid
- Vol. 5
Three-dimensional bioprinting techniques for cancer: organoid models and applications
Three-dimensional (3D) bioprinting has emerged as a promising technology for cancer research and treatment, offering unprecedented capabilities for fabricating complex tissue models and enabling personalized medicine. This review provides an overview of 3D bioprinting applications in cancer research, with a particular focus on organoid models. Organoid models, generated from patient-derived cells, have attracted considerable attention for their ability to reproduce the cellular and architectural complexity of tumors. The integration of 3D bioprinting technology into organoid generation allows precise assembly of multiple cell types, extracellular matrix components, and biomaterials, thereby enabling the creation of realistic tumor microenvironments. These bioprinted organoid models serve as valuable tools for studying cancer progression, conducting drug screening, and advancing personalized therapy.
- Open Access
- 26 July 2023
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 13 (33) , 22905-22917
Ecotoxicological significance of bio-corona formation on micro/nanoplastics in aquatic organisms
Biocorona formation on M/NPs potentially impacts the eco-toxicity and fate and transport of M/NPs in the aquatic environment.
- 26 July 2023
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 13 (33) , 22905-22917
Open AccessEcotoxicological significance of bio-corona formation on micro/nanoplastics in aquatic organisms
Biocorona formation on M/NPs potentially impacts the eco-toxicity and fate and transport of M/NPs in the aquatic environment.
- Top Cited PapersOpen Access
- 14 March 2023
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 13 (13) , 8606-8629
Cancer nanomedicine: a review of nano-therapeutics and challenges ahead
Cancer is known as the most dangerous disease in the world in terms of mortality and lack of effective treatment. Research on cancer treatment is still active and of great social importance. Since 1930, chemotherapeutics have been used to treat cancer. However, such conventional treatments are associated with pain, side effects, and a lack of targeting. Nanomedicines are an emerging alternative due to their targeting, bioavailability, and low toxicity. Nanoparticles target cancer cells via active and passive mechanisms. Since FDA approval for Doxil®, several nano-therapeutics have been developed, and a few have received approval for use in cancer treatment. Along with liposomes, solid lipid nanoparticles, polymeric nanoparticles, and nanoemulsions, even newer techniques involving extracellular vesicles (EVs) and thermal nanomaterials are now being researched and implemented in practice. This review highlights the evolution and current status of cancer therapy, with a focus on clinical/pre-clinical nanomedicine cancer studies. Insight is also provided into the prospects in this regard.
- 14 March 2023
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 13 (13) , 8606-8629
Top Cited PapersOpen AccessCancer nanomedicine: a review of nano-therapeutics and challenges ahead
Cancer is known as the most dangerous disease in the world in terms of mortality and lack of effective treatment. Research on cancer treatment is still active and of great social importance. Since 1930, chemotherapeutics have been used to treat cancer. However, such conventional treatments are associated with pain, side effects, and a lack of targeting. Nanomedicines are an emerging alternative due to their targeting, bioavailability, and low toxicity. Nanoparticles target cancer cells via active and passive mechanisms. Since FDA approval for Doxil®, several nano-therapeutics have been developed, and a few have received approval for use in cancer treatment. Along with liposomes, solid lipid nanoparticles, polymeric nanoparticles, and nanoemulsions, even newer techniques involving extracellular vesicles (EVs) and thermal nanomaterials are now being researched and implemented in practice. This review highlights the evolution and current status of cancer therapy, with a focus on clinical/pre-clinical nanomedicine cancer studies. Insight is also provided into the prospects in this regard.
- 11 August 2021
- Published by Springer Nature in BioNanoScience
- Vol. 11 (4) , 1017-1029
Nanoemulsion of Mentha arvensis Essential Oil as an Anticancer Agent in Anaplastic Thyroid Cancer Cells and as an Antibacterial Agent in Staphylococcus aureus
- 11 August 2021
- Published by Springer Nature in BioNanoScience
- Vol. 11 (4) , 1017-1029
Nanoemulsion of Mentha arvensis Essential Oil as an Anticancer Agent in Anaplastic Thyroid Cancer Cells and as an Antibacterial Agent in Staphylococcus aureus
- Open Access
- 1 October 2020
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 15, 7651-7666
Preparation of Celery Essential Oil-Based Nanoemulsion by Ultrasonication and Evaluation of Its Potential Anticancer and Antibacterial Activity
Introduction: Plants have always been a significant source of natural active components with biological properties. Celery seed oil (extracted from Apium graveolens) has several potential applications, but its therapeutic uses in the form of nanoemulsion formulation need to be investigated further in order to meet the demand in cancer treatment, and to alleviate the prevailing crisis arising from increased antimicrobial resistance. Methods: The therapeutic potential of celery seed oil was investigated through the formulation and testing of a nanoemulsion developed with Tween 80 (a non-ionic surfactant) and the utilization of an ultrasonication technique. Anticancer and apoptotic properties of the formulation were evaluated through MTT and Annexin V-FITC assays. The clonogenic assay aided in the identification of the antiproliferative properties of the formulation on oral squamous cell carcinoma. The antimicrobial study was supported by agar well diffusion assay, membrane integrity test and scanning electron microscopy. Results: Experiments identified relevant parameters, including optimal surfactant concentration and emulsification time. GC-MS analysis identified various components in the celery oil, but not their biological activities. A sonication time of 20 min resulted in a droplet diameter of 23.4 ± 1.80 nm. The IC50 concentration of the optimal nanoemulsion formulation against SAS cells was 1.4 μL/mL. At this concentration, cell proliferation was significantly reduced through inhibition of the anchorage-independent cell growth by disrupting colony formation and inducing cell death (apoptosis) of cancer cells. The nanoemulsion was also treated with a microbial suspension of S. aureus, and displayed antibacterial properties through lipid membrane fusion, causing cytoplasmic leakage as verified through agar well diffusion and membrane permeability assays. Scanning electron microscopy revealed complete distortion of the bacterial pathogen. Conclusion: The results in this study present celery as a possible constituent for cancer therapeutics and as a candidate for aggressive, yet safe cancer treatment. The celery-based nanoemulsion has the potential to act as a key alternative to standard antibiotic therapy.
- 1 October 2020
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 15, 7651-7666
Open AccessPreparation of Celery Essential Oil-Based Nanoemulsion by Ultrasonication and Evaluation of Its Potential Anticancer and Antibacterial Activity
Introduction: Plants have always been a significant source of natural active components with biological properties. Celery seed oil (extracted from Apium graveolens) has several potential applications, but its therapeutic uses in the form of nanoemulsion formulation need to be investigated further in order to meet the demand in cancer treatment, and to alleviate the prevailing crisis arising from increased antimicrobial resistance. Methods: The therapeutic potential of celery seed oil was investigated through the formulation and testing of a nanoemulsion developed with Tween 80 (a non-ionic surfactant) and the utilization of an ultrasonication technique. Anticancer and apoptotic properties of the formulation were evaluated through MTT and Annexin V-FITC assays. The clonogenic assay aided in the identification of the antiproliferative properties of the formulation on oral squamous cell carcinoma. The antimicrobial study was supported by agar well diffusion assay, membrane integrity test and scanning electron microscopy. Results: Experiments identified relevant parameters, including optimal surfactant concentration and emulsification time. GC-MS analysis identified various components in the celery oil, but not their biological activities. A sonication time of 20 min resulted in a droplet diameter of 23.4 ± 1.80 nm. The IC50 concentration of the optimal nanoemulsion formulation against SAS cells was 1.4 μL/mL. At this concentration, cell proliferation was significantly reduced through inhibition of the anchorage-independent cell growth by disrupting colony formation and inducing cell death (apoptosis) of cancer cells. The nanoemulsion was also treated with a microbial suspension of S. aureus, and displayed antibacterial properties through lipid membrane fusion, causing cytoplasmic leakage as verified through agar well diffusion and membrane permeability assays. Scanning electron microscopy revealed complete distortion of the bacterial pathogen. Conclusion: The results in this study present celery as a possible constituent for cancer therapeutics and as a candidate for aggressive, yet safe cancer treatment. The celery-based nanoemulsion has the potential to act as a key alternative to standard antibiotic therapy.
- Open Access
- 1 February 2020
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 15, 795-807
Ultrasonic Nanoemulsification of Cuminum cyminum Essential Oil and Its Applications in Medicine
Background and Study: Cumin seed oil (extracted from Cuminum cyminum) has many applications but conclusive evidence of its therapeutic uses has not been presented. This study has explored the anticancer and antibacterial properties of the seed oil. Methods: The cumin nanoemulsion was prepared with Tween 80 non-ionic surfactant employing ultra-sonication technology. The anticancer activity of the nanoscale-based emulsion was evaluated through cell viability (MTT), antiproliferation evaluation through clonogenic assay, and apoptosis through Annexin V-FITC assay. Agar well diffusion was used to study the antimicrobial activity, and this was supported by membrane integrity analysis. Results: A thorough study of process parameters, aimed at obtaining the optimal surface concentration and emulsification time, was completed. GC-MS data indicated cumaldehyde as a major component. The resultant droplet diameter after a sonication time of 5 min was 10.4 ± 0.5 nm. MTT assay revealed the IC 50 value at 1.5 μL/mL and the early induction of apoptosis was evident. Tongue carcinoma cell line treated with cumin nanoemulsion presented a diminished colony formation. The nanoemulsion exhibited significant antibacterial activity against S. aureus. A significant cytoplasmic leakage was observed on treatment with cumin nanoemulsion. The consequences of the analysis projected cumin as a potential component for cancer therapy. Conclusion: This study provides definitive evidence for cumin essential oil nanoemulsion as a legitimate plant-based medicine that can bypass the drawbacks of the present aggressive treatment of cancer, can overcome the antimicrobial resistance, and can also meet all prerequisites.
- 1 February 2020
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 15, 795-807
Open AccessUltrasonic Nanoemulsification of Cuminum cyminum Essential Oil and Its Applications in Medicine
Background and Study: Cumin seed oil (extracted from Cuminum cyminum) has many applications but conclusive evidence of its therapeutic uses has not been presented. This study has explored the anticancer and antibacterial properties of the seed oil. Methods: The cumin nanoemulsion was prepared with Tween 80 non-ionic surfactant employing ultra-sonication technology. The anticancer activity of the nanoscale-based emulsion was evaluated through cell viability (MTT), antiproliferation evaluation through clonogenic assay, and apoptosis through Annexin V-FITC assay. Agar well diffusion was used to study the antimicrobial activity, and this was supported by membrane integrity analysis. Results: A thorough study of process parameters, aimed at obtaining the optimal surface concentration and emulsification time, was completed. GC-MS data indicated cumaldehyde as a major component. The resultant droplet diameter after a sonication time of 5 min was 10.4 ± 0.5 nm. MTT assay revealed the IC 50 value at 1.5 μL/mL and the early induction of apoptosis was evident. Tongue carcinoma cell line treated with cumin nanoemulsion presented a diminished colony formation. The nanoemulsion exhibited significant antibacterial activity against S. aureus. A significant cytoplasmic leakage was observed on treatment with cumin nanoemulsion. The consequences of the analysis projected cumin as a potential component for cancer therapy. Conclusion: This study provides definitive evidence for cumin essential oil nanoemulsion as a legitimate plant-based medicine that can bypass the drawbacks of the present aggressive treatment of cancer, can overcome the antimicrobial resistance, and can also meet all prerequisites.
- Open Access
- 1 August 2019
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 14, 6439-6450
Anticancer and antibacterial effects of a clove bud essential oil-based nanoscale emulsion system
Background and purpose: The essential oil derived from clove buds (Syzygium aromaticum) has been used as a chemopreventive agent in Ayurvedic medicine. The antiviral, antibacterial, and anticancer properties of its chemo-skeleton have motivated this study to explore its efficacy in pharmaceutics. Methods: Nanoscale-based emulsions were prepared by employing a spontaneous emulsification technique through self-assembly using varying concentrations of Tween 20 and Tween 80 surfactants. Their physicochemical properties and stability were studied in order to choose an optimum formulation which was clear and stable. The cytotoxicity of the stable oil-based emulsion system was evaluated using MTT assay, colony formation assay, and Annexin V-FITC assay against the thyroid cancer cell line (HTh-7). Results: All three methods verified apoptosis and reduction in cancer cell proliferation, making the formulation a promising candidate as an alternative cancer drug. The oil-based emulsion system was also tested for its antibacterial properties against Staphylococcus aureus. Membrane permeability studies proved its efficacy to permeate through cell membrane, thereby increasing the leakage of cytoplasmic contents. Conclusion: Many current treatments for cancers are aggressive yet ineffective. This study positions the clove bud-based nanoscale emulsion as a suitable candidate for further in vivo studies and trials as a cancer drug.
- 1 August 2019
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 14, 6439-6450
Open AccessAnticancer and antibacterial effects of a clove bud essential oil-based nanoscale emulsion system
Background and purpose: The essential oil derived from clove buds (Syzygium aromaticum) has been used as a chemopreventive agent in Ayurvedic medicine. The antiviral, antibacterial, and anticancer properties of its chemo-skeleton have motivated this study to explore its efficacy in pharmaceutics. Methods: Nanoscale-based emulsions were prepared by employing a spontaneous emulsification technique through self-assembly using varying concentrations of Tween 20 and Tween 80 surfactants. Their physicochemical properties and stability were studied in order to choose an optimum formulation which was clear and stable. The cytotoxicity of the stable oil-based emulsion system was evaluated using MTT assay, colony formation assay, and Annexin V-FITC assay against the thyroid cancer cell line (HTh-7). Results: All three methods verified apoptosis and reduction in cancer cell proliferation, making the formulation a promising candidate as an alternative cancer drug. The oil-based emulsion system was also tested for its antibacterial properties against Staphylococcus aureus. Membrane permeability studies proved its efficacy to permeate through cell membrane, thereby increasing the leakage of cytoplasmic contents. Conclusion: Many current treatments for cancers are aggressive yet ineffective. This study positions the clove bud-based nanoscale emulsion as a suitable candidate for further in vivo studies and trials as a cancer drug.
- 1 June 2014
- Published by American Scientific Publishers in Nanomedicine and Nanobiology
- Vol. 1 (1) , 43-50
Physico-Chemical Characterization of Ramipril Using Clove Oil Based Microemulsion Drug Delivery System
Ramipril, an effective angiotensin converting enzyme inhibitor is used in the treatment of hypertension to chronic cardiac failure. The drug is highly lipophilic and sensitive that exhibits poor water solubility and relatively low bioavailability. Hence, a unique formulation by altering its physico-chemical characteristics is required. The drug being soluble in clove oil to a greater extent, a simple microemulsion system is formulated with no input of high-energy methods. Ternary phase diagram studies were constructed to identify the clear oil-in-water zone and the microemulsion formed was subjected to extreme conditions to determine the thermodynamic stability of the system. Conductivity, pH, viscosity and droplet size measurements were done to understand the internal physico-chemical state of the formulated microemulsions. Significant reduction in the particle size of the drug to 10–45 nm was seen when incorporated into the system comprising of clove oil, tween 20 and water (5:30:65 v/v%) as confirmed by dynamic light scattering method and transmission electron microscopic studies. The size reduction would improve the biological efficacy of the drug in-vivo after oral administration.
- 1 June 2014
- Published by American Scientific Publishers in Nanomedicine and Nanobiology
- Vol. 1 (1) , 43-50
Physico-Chemical Characterization of Ramipril Using Clove Oil Based Microemulsion Drug Delivery System
Ramipril, an effective angiotensin converting enzyme inhibitor is used in the treatment of hypertension to chronic cardiac failure. The drug is highly lipophilic and sensitive that exhibits poor water solubility and relatively low bioavailability. Hence, a unique formulation by altering its physico-chemical characteristics is required. The drug being soluble in clove oil to a greater extent, a simple microemulsion system is formulated with no input of high-energy methods. Ternary phase diagram studies were constructed to identify the clear oil-in-water zone and the microemulsion formed was subjected to extreme conditions to determine the thermodynamic stability of the system. Conductivity, pH, viscosity and droplet size measurements were done to understand the internal physico-chemical state of the formulated microemulsions. Significant reduction in the particle size of the drug to 10–45 nm was seen when incorporated into the system comprising of clove oil, tween 20 and water (5:30:65 v/v%) as confirmed by dynamic light scattering method and transmission electron microscopic studies. The size reduction would improve the biological efficacy of the drug in-vivo after oral administration.